leisure time -WSS

leisure time

author：hotspot 2025-10-01 14:20:20 - browse：693

Surgeons look over an x-ray monitor showing an implanted pacemaker — coverage from STAT — Adobe

In her final presentation for health policy class at the University of Chicago, first-year medical student Robin Ji informed her classmates that the Food and Drug Administration does not require randomized controlled trials of most medical devices. Her peers’ immediate reaction was disbelief.

“One classmate kept asking me, are you sure?” Ji said. “I think he asked me twice. Then he went on his phone to check to see if it was actually true.”

Ji was sure. She had spent two years before going to medical school working as a policy analyst for Rita Redberg and Sanket Dhruva, medical safety experts at the University of California, San Francisco. In a recent national survey published by the UCSF team in Health Affairs, Ji learned that it’s not just her classmates who may have misconceptions about the FDA — only 17% of physicians surveyed felt they understood the FDA’s device approval process. Around 41% felt they understood the drug side.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Diversify hospital leadership teams to protect BIPOC patient health

hotspot

WSS

Hospitals consider fixing cancer drug shortages on their own

More doctors should go into startup world

IRA could hurt research into orphan drugs for rare diseases

Study: New antibiotic targets gonorrhea as well as last existing drug

FDA proposes changes to key medical devices approval pathway

White House calls on federal agencies to crack down on AI abuses

focus

leisure time

hotspot

Jerome Adams on the need for new antivirals for Covid

The new shift in health care is toward less care

Anesthesiologist group: stop taking Ozempic before surgery

White House touts steps to stem shortages of cancer treatments

State Dept. review finds Biden bears some blame for Afghanistan failures

Will the IRA bring competition to the biologics market?

In Memoriam: Notable people who died in 2023

Food makers to regulators: Ultra

In Memoriam: Notable people who died in 2023

Diversify hospital leadership teams to protect BIPOC patient health

focus

Telehealth for opioid use disorder is lifesaving

How housing is health care on Long Island

Diverse clinical trials: Why aren’t we there yet?

WATCH: Why do bright lights make us see spots?

New weight loss drugs vying to be the next Wegovy or Mounjaro

The new shift in health care is toward less care

entertainment

hotspot

hotspot

leisure time